Protagonist Therapeutics (PTGX) Other Non-Current Assets (2015 - 2026)

Protagonist Therapeutics has reported Other Non-Current Assets for 12 years, with the latest figure at $288000.0 in Q1 2026.

• Quarterly Other Non-Current Assets rose 28.0% year-over-year to $288000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $288000.0 (up 28.0% YoY) and the FY2025 annual result came in at $287000.0, up 27.56% from the prior year.
• Other Non-Current Assets held at $288000.0 in Q1 2026 per PTGX's latest filing, from $287000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $290000.0 in Q2 2025 and troughed at $225000.0 in Q1 2022.
• A 5-year average of $239823.5 and a median of $225000.0 in 2022 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets changed 0.0% in 2022, then gained 28.89% in 2025.
• Over 5 years, Other Non-Current Assets stood at $225000.0 in 2022, then changed by 0.0% to $225000.0 in 2023, then changed by 0.0% to $225000.0 in 2024, then grew by 27.56% to $287000.0 in 2025, then advanced by 0.35% to $288000.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $288000.0, $287000.0, and $287000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.